SB 465-FN (2026): classifying xylazine as a schedule III controlled drug.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA: “SB 465-FN (2026): classifying xylazine as a schedule III controlled drug.” Granite Record, https://graniterecord.org/bill/2026/sb465. Accessed 19 Oct. 2026.
APA: Granite Record. (n.d.). SB 465-FN (2026): classifying xylazine as a schedule III controlled drug. Retrieved 19 Oct. 2026, from https://graniterecord.org/bill/2026/sb465
Chicago: Granite Record. “SB 465-FN (2026): classifying xylazine as a schedule III controlled drug.” Accessed 19 Oct. 2026. https://graniterecord.org/bill/2026/sb465.
BibTeX: @misc{bill-2026-sb465, title = {SB 465-FN (2026): classifying xylazine as a schedule III controlled drug.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2026/sb465}, note = {Accessed 19 Oct. 2026} }

SB 465-FN (2026)

classifying xylazine as a schedule III controlled drug.

Status: Killed
Term: 2025-2026
House committee: Environment and Agriculture
Senate committee: Judiciary
Subject: Crimes, Criminal Procedure and Corrections

The Story

It was introduced on January 7, 2026 and referred to the Senate Judiciary committee. The committee voted unanimously, 5–0, to recommend that the Senate pass it with changes (amendment 2026-0842s), and the report was placed on the consent calendar. The committee's amendment (2026-0842s) was adopted on a voice vote on March 5, 2026, changing the text of the bill. On March 5, 2026 the Senate voted to pass it with changes on a voice vote and ordered it to a third reading. It crossed to the House on March 12, 2026 and was referred to the House Environment and Agriculture committee. The committee held a public hearing on March 31, 2026, with 8 people signed in online: 6 in support and 2 in opposition. The committee held a work session on April 7, 2026. The committee met in executive session on April 14, 2026 to vote on its recommendation. The majority recommended that the House kill it, and the minority recommended that the House pass it, by a vote of 11–5. The report was placed on the regular calendar. On April 23, 2026 the House voted to kill it on a voice vote.

Hearings and Sessions

February 10, 2026, 1:30 PM: hearing, Senate Judiciary, SH 100
March 5, 2026: consent calendar, Senate
March 31, 2026, 1:30 PM: public hearing, House Environment and Agriculture, GP 153
April 7, 2026, 1:00 PM: full committee work session, House Environment and Agriculture, GP 153
April 14, 2026, 1:00 PM: executive session, House Environment and Agriculture, GP 153
April 23, 2026: floor debate, House

Votes

March 5, 2026, Senate: Ought to Pass with Amendment #2026-0842s — voice vote, passed
April 23, 2026, House: Inexpedient to Legislate — voice vote, passed

The Docket

January 7, 2026: Introduced 01/07/2026 and Referred to Judiciary
February 10, 2026: Hearing: 02/10/2026, Room 100, SH, 01:30 pm; SC 5A
March 5, 2026: Committee Report: Ought to Pass with Amendment # 2026-0842s, 03/05/2026; Vote 5-0; CC
March 5, 2026: Committee Amendment # 2026-0842s, AA, VV; 03/05/2026
March 5, 2026: Ought to Pass with Amendment #2026-0842s, MA, VV; OT3rdg; 03/05/2026
March 12, 2026: Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture
March 31, 2026: Public Hearing: 03/31/2026 01:30 pm GP 153
April 7, 2026: Full Committee Work Session: 04/07/2026 01:00 pm GP 153
April 14, 2026: Executive Session: 04/14/2026 01:00 pm GP 153
April 14, 2026: Majority Committee Report: Inexpedient to Legislate 04/14/2026 (Vote 11-5; RC)
April 15, 2026: Minority Committee Report: Ought to Pass
April 23, 2026: Inexpedient to Legislate: MA VV 04/23/2026

Laws It Would Change

RSA 318-B